PriceTargets.com logo

DSM-Firmenich - KDSKF Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$25.30 As of 10/17/2024 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for KDSKF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New DSM-Firmenich Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for KDSKF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for KDSKF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for DSM-Firmenich in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $25.30.

This chart shows the closing price for KDSKF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in DSM-Firmenich. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/9/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/7/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/5/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/3/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/3/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/1/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/30/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/30/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/21/2023JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight
7/9/2023The Goldman Sachs GroupInitiated CoverageBuy
7/3/2023Stifel NicolausDowngradeBuy ➝ Hold
(Data available from 10/30/2019 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2024
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
5/3/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
6/2/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/2/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/1/2024
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/31/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/30/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/30/2024

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
DSM-Firmenich logo
DSM the Life Sciences and Materials Sciences Company Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSMs products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM has annual net sales of EUR 9.3 billion and employs some 23,500 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam.
Read More

Today's Range

Now: $25.30
Low: $25.30
High: $25.30

50 Day Range

MA: $25.30
Low: $25.30
High: $25.30

52 Week Range

Now: $25.30
Low: $12.50
High: $120.00

Volume

N/A

Average Volume

303 shs

Market Capitalization

N/A

P/E Ratio

26.69

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of DSM-Firmenich?

The following equities research analysts have issued reports on DSM-Firmenich in the last year:
View the latest analyst ratings for KDSKF.

What is the current price target for DSM-Firmenich?

0 Wall Street analysts have set twelve-month price targets for DSM-Firmenich in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for DSM-Firmenich in the next year.
View the latest price targets for KDSKF.

What is the current consensus analyst rating for DSM-Firmenich?

DSM-Firmenich currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for KDSKF.

What other companies compete with DSM-Firmenich?

Other companies that are similar to DSM-Firmenich include AirBoss of America, Akzo Nobel, Alfa, ALPEK and Avantium. Learn More about companies similar to DSM-Firmenich.

How do I contact DSM-Firmenich's investor relations team?

DSM-Firmenich's physical mailing address is Het Overloon 1, Heerlen 6411 TE, Netherlands. The company's listed phone number is (145) 578-8111. The official website for DSM-Firmenich is www.dsm.com. Learn More about contacing DSM-Firmenich investor relations.